PHARMA
PHARMAPharmaceutical Hydrogenation Membrane in Spain
Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Spain's abundant solar resources and industrial base make it a natural hub for green hydrogen production in Europe.
Market Context
SpainPolicy
H₂ Target
Cities
Industries
Ultra-Clean Hydrogen Source
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
GMP-Compatible On-Site Generation
On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.
Batch-Flexible Operation
Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.
Pharmaceutical Hydrogenation in Spain’s Hydrogen Market
Spain's abundant solar resources and industrial base make it a natural hub for green hydrogen production in Europe. The Basque Country and Catalonia host key industrial hydrogen consumers in steel, refining, and chemicals. Spain targets 4 GW of electrolyser capacity by 2030, supported by some of Europe's lowest renewable electricity costs.
IONZERA's high efficiency maximizes the hydrogen output per kWh of Spanish solar electricity, improving the economics of solar-to-hydrogen projects. Competitive pricing from Indian manufacturing strengthens the cost case for Spanish green hydrogen.
Lower Resistance
Thinner Profile
PERFORMANCE ADVANTAGE
Why IONZERA for Pharmaceutical Hydrogenation in Spain
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
Shipping & Logistics
Air freight from India in 5-7 business days to Bilbao or Barcelona.
Area Resistance
3x LOWERThickness
20% THINNERFrequently Asked Questions
Why choose IONZERA for pharmaceutical hydrogenation in Spain?
IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Spain. IONZERA's high efficiency maximizes the hydrogen output per kWh of Spanish solar electricity, improving the economics of solar-to-hydrogen projects.
Is IONZERA suitable for solar-to-hydrogen projects in Spain?
Yes. IONZERA's 3x lower resistance reduces electricity consumption per kg of H2, making it particularly advantageous for solar-powered electrolysis where maximizing hydrogen output per solar kWh is critical.
Can IONZERA membranes handle intermittent solar power operation?
IONZERA is designed for alkaline electrolysis systems that handle variable loads from renewable sources. Its chemical stability in 30 wt% KOH and mechanical strength ensure reliable performance across operating cycles.
EXPLORE MORE
Request Pharmaceutical Hydrogenation Samples for Spain
Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Spain-based projects.
Request Sample